The Centers for Medicare and Medicaid Services signaled in a Wednesday statement that it will continue the Inflation Reduction Act’s Medicare Part D drug price negotiations.

Trump Administration Signals Support for IRA Drug Price Negotiations

The Trump Administration indicated Wednesday that it will continue the Inflation Reduction Act’s (IRA) Medicare drug price negotiations, a signature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.